Totect

Active Ingredient(s): Dexrazoxane Hydrochloride
FDA Approved: * September 6, 2007
Pharm Company: * TOPOTARGET
Category: Cancer

Dexrazoxane hydrochloride (Zinecard, Cardioxane) is a cardioprotective agent. It was discovered by Eugene Herman in 1972. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.[1] Contents 1 Uses 2 Mechanism 3 References 4 External links Uses Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs such as anthracyclines,[2] such as daunorubicin or doxorubicin or other c... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Totect Intravenous Kit
NDC: 38423-110
Labeler:
Topotarget USA
Totect 500 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 66220-110
Labeler:
Cumberland Pharmaceuticals Inc.
Totect 500 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 76310-110
Labeler:
Clinigen Group Plc

Related Brands

Drugs with the same active ingredients